Africa: Acoziborole Winthrop, Developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as Three-tablet, Single-Dose Treatment For Most Common Form of Sleeping Sickness

Africa: Acoziborole Winthrop, Developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as Three-tablet, Single-Dose Treatment For Most Common Form of Sleeping Sickness

Kinshasa / Paris / Geneva / Amsterdam — • Recommendation based on Phase II/III study demonstrating up to 96 per cent success rates at 18 months across both early and advanced stages of T.b. gambiense, the most common form of sleeping sickness • The therapy, given as a single dose of three tablets, could offer a simpler…

Read More
Africa: HIV Prevention and Treatment Services Faltering, Warns UNAIDS

Africa: HIV Studies Call for Africa-Specific Data to Optimise Treatment Strategies

Nairobi — New HIV research presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) has revealed critical evidence gaps that experts say must be urgently addressed to strengthen HIV treatment strategies across Africa. Researchers from the Centre for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi presented findings from…

Read More